346 related articles for article (PubMed ID: 25662060)
1. Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.
Kiviniemi T; Airaksinen KE; Rubboli A; Biancari F; Valencia J; Lip GY; Karjalainen PP; Weber M; Laine M; Kirchhof P; Schlitt A;
Int J Cardiol; 2015 Mar; 183():105-10. PubMed ID: 25662060
[TBL] [Abstract][Full Text] [Related]
2. Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.
Proietti M; Airaksinen KEJ; Rubboli A; Schlitt A; Kiviniemi T; Karjalainen PP; Lip GYH;
Clin Res Cardiol; 2017 Jun; 106(6):420-427. PubMed ID: 28078448
[TBL] [Abstract][Full Text] [Related]
3. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.
Kiviniemi T; Karjalainen P; Rubboli A; Schlitt A; Tuomainen P; Niemelä M; Laine M; Biancari F; Lip GY; Airaksinen KE
Am J Cardiol; 2013 Aug; 112(4):493-8. PubMed ID: 23672991
[TBL] [Abstract][Full Text] [Related]
5. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
Mennuni MG; Halperin JL; Bansilal S; Schoos MM; Theodoropoulos KN; Meelu OA; Sartori S; Giacoppo D; Bernelli C; Moreno PR; Krishnan P; Baber U; Lucarelli C; Dangas GD; Sharma SK; Kini AS; Tamburino C; Chieffo A; Colombo A; Presbitero P; Mehran R
Am J Cardiol; 2015 Jul; 116(1):37-42. PubMed ID: 25956624
[TBL] [Abstract][Full Text] [Related]
6. One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry.
Rubboli A; Schlitt A; Kiviniemi T; Biancari F; Karjalainen PP; Valencia J; Laine M; Kirchhof P; Niemelä M; Vikman S; Lip GY; Airaksinen KE;
Clin Cardiol; 2014 Jun; 37(6):357-64. PubMed ID: 24481953
[TBL] [Abstract][Full Text] [Related]
7. Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.
Proietti M; Airaksinen KEJ; Rubboli A; Schlitt A; Kiviniemi T; Karjalainen PP; Lip GY;
Am Heart J; 2017 Aug; 190():86-93. PubMed ID: 28760217
[TBL] [Abstract][Full Text] [Related]
8. Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery.
Capodanno D; Musumeci G; Lettieri C; Limbruno U; Senni M; Guagliumi G; Valsecchi O; Angiolillo DJ; Rossini R
Thromb Haemost; 2015 Aug; 114(2):423-31. PubMed ID: 26017898
[TBL] [Abstract][Full Text] [Related]
9. Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
Lahtela HM; Bah A; Kiviniemi T; Nammas W; Schlitt A; Rubboli A; Karjalainen PP; Proietti M; Hartikainen JEK; Lip GYH; Airaksinen KEJ
Clin Cardiol; 2017 Dec; 40(12):1264-1270. PubMed ID: 29243834
[TBL] [Abstract][Full Text] [Related]
10. Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
Casamira N; García-Camarero T; Montoro-Ronsano JB; Veiga G; Del Blanco BG; De La Torre JM; Gordon B; García-Dorado D; Sambola A
Am J Med Sci; 2019 Aug; 358(2):95-103. PubMed ID: 31176420
[TBL] [Abstract][Full Text] [Related]
11. Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.
Lahtela H; Rubboli A; Schlitt A; Karjalainen PP; Niemelä M; Vikman S; Puurunen M; Weber M; Valencia J; Biancari F; Lip GY; Airaksinen KE;
Circ J; 2012; 76(6):1363-8. PubMed ID: 22447005
[TBL] [Abstract][Full Text] [Related]
12. Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification.
Sambola A; Mutuberría M; García Del Blanco B; Alonso A; Barrabés JA; Alfonso F; Bueno H; Cequier A; Zueco J; Rodríguez-Leor O; Bosch E; Tornos P; García-Dorado D
Circ J; 2016; 80(2):354-62. PubMed ID: 26725763
[TBL] [Abstract][Full Text] [Related]
13. Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.
Nammas W; Kiviniemi T; Schlitt A; Rubboli A; Valencia J; Lip GYH; Karjalainen PP; Biancari F; Juhani Airaksinen KE
Int J Cardiol; 2018 Feb; 253():35-39. PubMed ID: 29306469
[TBL] [Abstract][Full Text] [Related]
14. Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Kiviniemi T; Puurunen M; Schlitt A; Rubboli A; Karjalainen P; Nammas W; Kirchhof P; Biancari F; Lip GY; Airaksinen KJ
Circ J; 2014; 78(11):2674-81. PubMed ID: 25298168
[TBL] [Abstract][Full Text] [Related]
15. Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
Sambola A; Mutuberría M; García Del Blanco B; Alonso A; Barrabés JA; Bueno H; Alfonso F; Cequier A; Zueco J; Rodríguez-Leor O; Tornos P; García-Dorado D
PLoS One; 2016; 11(1):e0147245. PubMed ID: 26808678
[TBL] [Abstract][Full Text] [Related]
16. In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry.
Rubboli A; Sciahbasi A; Briguori C; Saia F; Palmieri C; Moroni LA; Calabrò P; Leone AM; Franco N; Valgimigli M; Varani E; Santi M; Pasqualini P; Capecchi A; Piccalò G; Margheri M; di Pasquale G; Galvani M; Bolognese L; Gonzini L; Maggioni AP;
J Invasive Cardiol; 2013 Apr; 25(4):170-6. PubMed ID: 23549489
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
18. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of bridging therapy with fondaparinux versus low-molecular-weight heparin in patients undergoing atrial fibrillation ablation.
Zhang F; Zhao D; Peng X; Yang H; Zhu T; Huang F; Peng J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):448-52. PubMed ID: 24752085
[TBL] [Abstract][Full Text] [Related]
20. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
